Advertisement
Science
How Eli Lilly’s new GLP‑1 pill stacks up against Wegovy and other weight‑loss drugs
April 2, 2026
Scientific American
Scroll
This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks
Scientific American
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: Unknown
Advertisement